JP2006519831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519831A5 JP2006519831A5 JP2006506264A JP2006506264A JP2006519831A5 JP 2006519831 A5 JP2006519831 A5 JP 2006519831A5 JP 2006506264 A JP2006506264 A JP 2006506264A JP 2006506264 A JP2006506264 A JP 2006506264A JP 2006519831 A5 JP2006519831 A5 JP 2006519831A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- disorder
- disorders
- tetrazol
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(*)(*)C(C)(*)N Chemical compound CC(*)(*)C(C)(*)N 0.000 description 3
- MSHWTKGAZGNGGH-UHFFFAOYSA-N CC(C)C(N1)=NOC1=O Chemical compound CC(C)C(N1)=NOC1=O MSHWTKGAZGNGGH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45287103P | 2003-03-07 | 2003-03-07 | |
| PCT/IB2004/000510 WO2004078734A1 (en) | 2003-03-07 | 2004-02-23 | TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519831A JP2006519831A (ja) | 2006-08-31 |
| JP2006519831A5 true JP2006519831A5 (enExample) | 2007-03-01 |
Family
ID=32962749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506264A Withdrawn JP2006519831A (ja) | 2003-03-07 | 2004-02-23 | テトラゾール及びオキサジアゾロン置換β−アミノ酸誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7250433B2 (enExample) |
| EP (1) | EP1603890A1 (enExample) |
| JP (1) | JP2006519831A (enExample) |
| BR (1) | BRPI0408110A (enExample) |
| CA (1) | CA2518218A1 (enExample) |
| MX (1) | MXPA05009504A (enExample) |
| WO (1) | WO2004078734A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070066591A1 (en) * | 2003-05-14 | 2007-03-22 | Xiangping Qian | Compounds, compositions, and methods |
| GB0521743D0 (en) * | 2005-10-25 | 2005-11-30 | Novartis Ag | Organic compounds |
| AU2013216828B2 (en) | 2012-02-09 | 2017-01-12 | Novus International Inc. | Functionalized polymer compositions |
| MX2015000395A (es) | 2012-07-12 | 2015-04-10 | Novus Int Inc | Composiciones de matriz y capa para proteccion de bioactivos. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| WO1999008670A1 (en) | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
| PL341291A1 (en) * | 1997-12-16 | 2001-04-09 | Warner Lambert Co | 1-substituted derivatives of 1-aminomethyl-ccycloalkanes (gabapentin analogues), their production and application of them in treating neurological disorders |
| BR9814287A (pt) * | 1997-12-16 | 2000-10-03 | Warner Lambert Co | "4(3)-aminometil-(tio)piran 4(3) substituìdo ou derivados da piperidina (= análogos da gabapentina), sua preparação e seu uso no tratamento de desordens neurológicas" |
| CN1210268C (zh) * | 1997-12-16 | 2005-07-13 | 沃尼尔·朗伯公司 | ((环)烷基取代的)－γ－氨基丁酸衍生物(=GABA类似物),其制备和在治疗神经病中的用途 |
| EP1082306A1 (en) * | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| BR9913701A (pt) | 1998-09-14 | 2001-06-05 | Warner Lambert Co | ácidos alquil pirrolidina-3-carboxìlicos ramificados |
| KR20040081478A (ko) | 2002-01-31 | 2004-09-21 | 워너-램버트 캄파니 엘엘씨 | 이명을 치료하기 위한 알파 2 델타 리간드 |
-
2004
- 2004-02-23 JP JP2006506264A patent/JP2006519831A/ja not_active Withdrawn
- 2004-02-23 MX MXPA05009504A patent/MXPA05009504A/es unknown
- 2004-02-23 BR BRPI0408110-2A patent/BRPI0408110A/pt not_active IP Right Cessation
- 2004-02-23 CA CA002518218A patent/CA2518218A1/en not_active Abandoned
- 2004-02-23 EP EP04713604A patent/EP1603890A1/en not_active Withdrawn
- 2004-02-23 WO PCT/IB2004/000510 patent/WO2004078734A1/en not_active Ceased
- 2004-03-08 US US10/795,760 patent/US7250433B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2586974C2 (ru) | Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств | |
| US9963454B2 (en) | Compounds and compositions for the treatment of parasitic disease | |
| JP2025121955A (ja) | Ｐｇｄｈ阻害剤、およびその作製と使用の方法 | |
| JP5860417B2 (ja) | カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 | |
| US9309224B2 (en) | N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| CN102164604A (zh) | 用作激酶调节剂的稠合杂环化合物 | |
| WO2005040135A1 (ja) | 抗ストレス薬およびその医薬用途 | |
| JP2010536752A5 (enExample) | ||
| RS56807B1 (sr) | Jedinjenja aminopirimidinila kao jak inhibitori | |
| WO2014058071A1 (ja) | シクロプロパンアミン化合物およびその用途 | |
| JP5552121B2 (ja) | ロイコトリエン産生のインドリジン阻害剤 | |
| CN1332741A (zh) | 作为选择性cox－2抑制剂的吡唑并吡啶衍生物 | |
| JP2014500332A (ja) | Ｆａａｈ阻害剤 | |
| JP5490100B2 (ja) | ５−（２−アミノ−ピリミジン−４−イル）−２−アリール−ｌＨ−ピロール−３−カルボキサミドの製造方法 | |
| US12195432B2 (en) | 2-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseases | |
| WO2011043359A1 (ja) | 芳香族複素環化合物を含有する医薬 | |
| TW200534850A (en) | Hydroisoindoline tachykinin receptor antagonists | |
| JP2024160326A (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| TW200835686A (en) | Novel compounds 621 | |
| JP5916730B2 (ja) | アミド化合物 | |
| JP7376358B2 (ja) | オピオイド受容体調節因子としての多環式アミン | |
| TW200423937A (en) | Quinazoline compounds | |
| US20130109721A1 (en) | FAAH Inhibitors | |
| AU2024248193A1 (en) | Quinolinone amide compounds and uses thereof | |
| EP1987007A1 (en) | 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases |